Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01925677 · ClinicalTrials.gov registry record · NA
Robotic Single Port Donor Nephrectomy
A NA study of Renal Transplant Donor of Left Kidney and Donor Nephrectomy, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT01925677 is a NA study of Renal Transplant Donor of Left Kidney and Donor Nephrectomy that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 3 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01925677, a NA study of Renal Transplant Donor of Left Kidney and Donor Nephrectomy, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
Feasibility study on robotic-assisted single-site donor nephrectomy utilizing da Vinci instrumentation and Single-Site platforms.
Conditions Studied
Interventions
- DEVICE da Vinci® Single-Site™
Study Locations (1)
Maryland
- University of Maryland Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01925677
The ClinicalTrials.gov registry entry for NCT01925677 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Renal Transplant Donor of Left Kidney appearing as the primary indexed condition, and to 1 intervention - of which da Vinci® Single-Site™ is the first listed.
NCT01925677 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01925677 about?
NCT01925677 is a clinical study titled "Robotic Single Port Donor Nephrectomy". Feasibility study on robotic-assisted single-site donor nephrectomy utilizing da Vinci instrumentation and Single-Site platforms.
What is the current status of trial NCT01925677?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2015-01. Estimated completion is 2017-08.
What conditions does trial NCT01925677 study?
This clinical trial studies the following conditions: Renal Transplant Donor of Left Kidney, Donor Nephrectomy, Robotic Surgery, Single-port.
What interventions are being tested in trial NCT01925677?
The interventions under investigation include: da Vinci® Single-Site™ (DEVICE).
Who is sponsoring clinical trial NCT01925677?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01925677 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.